Tirzepatid
A dual GIP/GLP-1 receptor agonist, known as an approved medication and listed here as a research substance for metabolic regulation.
Tirzepatide is a dual GIP/GLP-1 receptor agonist approved as a medication under the names Mounjaro and Zepbound. It is the subject of extensive clinical research on metabolic and weight regulation in type 2 diabetes and obesity. The research batches listed here are not equivalent to approved medications and are intended for laboratory use only.
Facts
- CAS number: 2023788-19-2
- Molecular weight: 4813 g/mol
- Amino acids: 39
- Halbwertszeit: ≈ 5 days (elimination, Mounjaro prescribing information)
- Purity specification: ≥ 99 % (HPLC, commercial standard)
Evidence
- In a randomized trial with 2,539 adults with obesity or overweight, weekly tirzepatide over 72 weeks led to a mean body weight loss of up to 20.9 percent (15 mg) versus 3.1 percent under placebo. Jastreboff AM et al. 2022, New England Journal of Medicine, PMID 35658024
- In a randomized head-to-head trial with 1,879 people with type 2 diabetes, tirzepatide lowered HbA1c by 2.09 to 2.46 percentage points and body weight by 7.8 to 12.4 kg after 40 weeks, in each case more than semaglutide 1 mg. Frías JP et al. 2021, New England Journal of Medicine, PMID 34170647
Frequently asked questions
Is tirzepatide an approved medication?
Yes, tirzepatide is approved as a prescription medication under the names Mounjaro and Zepbound. The substance described here is a research batch only, not a finished pharmaceutical product.
How does tirzepatide differ from semaglutide?
Semaglutide acts only on the GLP-1 receptor, while tirzepatide additionally acts on the GIP receptor. In a head-to-head trial, tirzepatide showed larger effects on HbA1c and body weight than semaglutide.
What is tirzepatide used for as a medication?
As an approved medication, tirzepatide is prescribed for type 2 diabetes and weight management. This page describes the substance exclusively as a research chemical for laboratory purposes.
Documented prices
List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.
| Vendor | Pack | List price | Price/mg | Recorded | Source |
|---|---|---|---|---|---|
| Peak Peptide | 5 mg | 39.9 EUR | 7.98 EUR/mg | 2026-09-15 | Product page · Ad |
| Europa-Peptide | 5 mg | 44.9 EUR | 8.98 EUR/mg | 2026-09-15 | Product page · Ad |
| Smart Peptides | 10 mg | 59.9 EUR | 5.99 EUR/mg | 2026-09-15 | Product page · Ad |
| Peptide Shop Deutschland | 10 mg | 84.99 EUR | 8.5 EUR/mg | not established | Product page · Ad |
| Licensed Peptides | 5 mg | 53.99 USD | 10.8 USD/mg | 2026-09-15 | Product page · Ad |
| American Peptides | 10 mg | 100 USD | 10.0 USD/mg | 2026-09-15 | Product page · Ad |
| Hydro Research Peptides | 15 mg | 124.99 USD | 8.33 USD/mg | 2026-09-15 | Product page · Ad |
| BioCollex | 20 mg | 80 USD | 4.0 USD/mg | 2026-09-15 | Product page · Ad |
Quick facts
What is being studied
Evidence
Safety
Legal status
Product documentation
Notes
Frequently asked questions
Related peptides
Choosing between vendors
Compare price and documentation
Vendors carrying this peptide
| Logo | Vendors | Vial (mg) | Price | Price/mg | CoA | Action |
|---|
No verified vendor currently carries this peptide.
Verified batches
| Batch number | Vendors | Purity | CoA status |
|---|
No verified batches are currently available for this peptide.
Next step
View vendors carrying this peptide